Skip to main content
A headshot of Daniel Grossman

Daniel Grossman, MD

ANSIRH Director and Professor

Daniel Grossman, MD, is ANSIRH's Director. He focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. Dr. Grossman is Vice Chair of Advocacy in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF and performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dr. Grossman received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.

The latest research

See all
April 13, 2026

Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States

Merz-Herrala AA, Biggs MA, Ehrenreich K, Kaller S, Ralph LJ, Scott KA, Kapp N, Kromenaker T, Perritt J, Kari White, Grossman D. Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States. BMC Health Services Research. April 2026; https://doi.org/10.1186/s12913-026-14505-2.
December 19, 2025

Lessons learned from the movement behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage

Nichols V, Maske A, Elliott R, Wahlin B, Blanchard K, Leong L, Rafie S, Grossman D, Schenk L, Nelson B, Downing D, Lin J, Cleland K, Robinson-Flint J, Hauser D. Lessons learned from the movement behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage. Contraception. December 2025; https://doi.org/10.1016/j.contraception.2025.111348.